A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasia

E-ISSN： 1464-410x|81|S1|56-63

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.81, Iss.S1, 1998-03, pp. : 56-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Benign Prostatic Hyperplasia: Diagnosis and Treatment

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 9, 1998-09 ,pp. : 1163-1165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Efficacy of Serenoa repens Treatment in Patients with Mild and Moderate Symptomatic Benign Prostatic Hyperplasia

Urologia Internationalis, Vol. 86, Iss. 3, 2011-02 ,pp. : 284-289

Karger

Access to resources Recommend Favorite

Dutasteride: 21st Century medical therapy for symptomatic benign prostatic hyperplasia

By Shergill Iqbal S Barua Jayanta M

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 383-386

Future Medicine

Access to resources Recommend Favorite

Effect of Terazosin on the Lipid Profile in Patients with Symptomatic Benign Prostatic Hyperplasia

Urologia Internationalis, Vol. 67, Iss. 2, 2001-08 ,pp. : 156-159

Karger

Access to resources Recommend Favorite

Interstitial Laser Coagulation in Benign Prostatic Hyperplasia: A Critical Evaluation after 2 Years of Follow-Up

Urologia Internationalis, Vol. 62, Iss. 2, 1999-08 ,pp. : 76-80

Karger

Access to resources Recommend Favorite